SULFABID Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Sulfabid, and what generic alternatives are available?
Sulfabid is a drug marketed by Pharm Res Assoc and Purdue Frederick and is included in two NDAs.
The generic ingredient in SULFABID is sulfaphenazole. Additional details are available on the sulfaphenazole profile page.
Summary for SULFABID
US Patents: | 0 |
Applicants: | 2 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 93 |
Patent Applications: | 1,607 |
Formulation / Manufacturing: | see details |
DailyMed Link: | SULFABID at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for SULFABID
US Patents and Regulatory Information for SULFABID
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pharm Res Assoc | SULFABID | sulfaphenazole | SUSPENSION;ORAL | 013093-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Purdue Frederick | SULFABID | sulfaphenazole | TABLET;ORAL | 013092-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |